Skip to Content


In the US, Eprosartan (eprosartan systemic) is a member of the drug class angiotensin receptor blockers and is used to treat High Blood Pressure.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name

2-tiophenepropanoic acid, α-[[2-butyl-1-[(4-carboxyphenyl)metyl]-1H-imidazol-5-yl]metylene]-, (E)-

Foreign Names

  • Eprosartanum (Latin)
  • Eprosartan (German)
  • Éprosartan (French)
  • Eprosartan (Spanish)

Generic Names

Brand Names

  • Eprosartan Mylan
    Mylan, Spain
  • Eprosartan Pensa
    Pensa Pharma, Spain
  • Teveten
    2care4, Norway; Abbott, Ecuador; Abbott, Poland; Abbott, Turkey; Abbott Laboratories S.A., China; BGP Products, Lithuania; BGP Products, Latvia; Solvay, Egypt; Solvay, Taiwan; Varnavas, Cyprus
  • Teveten Comp. [+ Hydrochlorothiazide]
    Mylan, Norway
  • Teveten Plus [+ Hydrochlorothiazide]
    Abbott, Ecuador; Abbott, Turkey; Abbott Laboratories, Cyprus
  • Emestar
    Abbott Arzneimittel, Germany
  • Epratenz
    Sanfer, Mexico
  • Epratenz Dox [+ Hydrochlorothiazide]
    Sanfer, Mexico
  • Eprosartan
    Activase Pharmaceuticals, United Kingdom
  • Eprosartan comp.-CT [+ Hydrochlorothiazide]
    AbZ-Pharma, Germany
  • Eprosartan Mesylate
    Mylan, United States
  • Eprosartan Mylan
    Generics UK, United Kingdom; Mylan, Netherlands
  • Eprosartan Teva
    Teva Nederland, Netherlands
  • Eprosartan Unichem
    Unichem, Netherlands
  • Eprosartan-CT
    AbZ-Pharma, Germany
  • Eprosartan-ratiopharm
    ratiopharm, Germany
  • Eprosartan-ratiopharm comp. [+ Hydrochlorothiazide]
    ratiopharm, Germany
  • Eprotan-Mepha 600mg
    Mepha Pharma, Switzerland
  • Eprotan-Mepha plus [+ Hydrochlorothiazide]
    Mepha Pharma, Switzerland
  • Futuran
    Mylan, Spain
  • Futuran Plus [+ Hydrochlorothiazide]
    Mylan, Spain
  • Naviten
    BGP Products, Slovakia
  • Naviten Combi [+ Hydrochlorothiazide]
    Abbott, Slovakia
  • Navixen
    Mylan, Spain
  • Navixen Plus [+ Hydrochlorothiazide]
    Ferrer Internacional, Spain
  • Regulaten
    Mylan, Spain
  • Regulaten Plus [+ Hydrochlorothiazide]
    Mylan, Spain
  • Tevastatin
    BGP-Produkte MEPE, Greece
  • Teveten
    Abbott, Colombia; Abbott, Hong Kong; Abbott, Malta; Abbott, Philippines; Abbott, Portugal; Abbott, Russian Federation; Abbott Biologicals, Macedonia; AbbVie, United States; BGP Pharma, Canada; BGP Products, Czech Republic; BGP Products, Estonia; BGP Products, Sweden; Mylan, Belgium; Mylan, Bulgaria; Mylan, France; Mylan, Netherlands; Mylan, Norway; Mylan EPD, Croatia (Hrvatska); Mylan Health, Australia; Mylan IRE Healthcare, Ireland; Mylan Products, United Kingdom; Solvay, Lebanon; Solvay Pharma, Indonesia
  • Teveten 600mg
    BGP Products, Austria; BGP Products, Switzerland; BGP Products, Hungary
  • Teveten Comp. [+ Hydrochlorothiazide]
    BGP Products, Sweden
  • Teveten Mono
    Mylan Healthcare, Germany
  • Teveten Plus [+ Hydrochlorothiazide]
    Abbott, Colombia; Abbott, Hong Kong; Abbott, Philippines; Abbott, Portugal; Abbott Laboratories, Lithuania; BGP Pharma, Canada; BGP Products, Switzerland; BGP Products, Malta; BGP-Produkte MEPE, Greece; Mylan, Belgium; Mylan, Bulgaria; Mylan, Netherlands; Mylan Health, Australia; Mylan Healthcare, Germany; Mylan IRE Healthcare, Ireland; Solvay, Lebanon; Solvay, Russian Federation
  • Teveten Plus 600mg/12.5mg [+ Hydrochlorothiazide]
    Abbott, Austria; Mylan, Luxembourg
  • Tevetens
    Mylan, Spain
  • Tevetens Plus [+ Hydrochlorothiazide]
    Abbott, Russian Federation; Mylan, Spain
  • Tevetenz
    Abbott Laboratories de México, Mexico; Solvay Pharma, Italy
  • Tevetenz Dox [+ Hydrochlorothiazide]
    Abbott Laboratories de México, Mexico
  • Tiartan [+ Hydrochlorothiazide]
    Solvay Pharma, Italy


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.